|
Showing 1 - 3 of
3 matches in All Departments
Controversy still exists regarding how early disease-modifying
agents (DMA) should be commenced and whether all patients with
relapsing-remitting MS should in fact be treated. To answer these
questions, it is also important to know the natural history of the
disease. MS affects nearly 400,000 people in the United States.
With their novel, multifaceted approach to basic science, the
authors of this book offer help to clinicians and hope to patients.
Controversy still exists regarding how early disease-modifying
agents (DMA) should be commenced and whether all patients with
relapsing-remitting MS should in fact be treated. To answer these
questions, it is also important to know the natural history of the
disease. MS affects nearly 400,000 people in the United States.
With their novel, multifaceted approach to basic science, the
authors of this book offer help to clinicians and hope to patients.
|
You may like...
Loot
Nadine Gordimer
Paperback
(2)
R398
R330
Discovery Miles 3 300
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.